Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Clove bud (Syzygium aromaticum) derives its potent bioactivity from eugenol (up to 85% of essential oil), which disrupts bacterial cell membranes via K⁺/ATP efflux and proton-motive force collapse, inhibits prostaglandin synthesis for analgesic effects, and demonstrates powerful antioxidant and immunomodulatory capacity — including anti-cancer potential confirmed by phytogenic silver nanoparticle studies (PMID 38085521). A 2023 study further validated that both acetylated and non-acetylated clove bud essential oils exhibit significant antibacterial activity against Gram-positive and Gram-negative pathogens, with eugenol and eugenyl acetate as principal active compounds (PMID 36892132).
Reported Benefits (Provisional)
Origin & History
Clove Bud, derived from Syzygium aromaticum, is native to the Maluku Islands (Spice Islands) of Indonesia, thriving in tropical climates with fertile soils and high humidity. Revered for its potent antimicrobial, anti-inflammatory, and digestive-supporting properties, Clove Bud has a long history in medicinal, culinary, and spiritual applications across Ayurvedic, Traditional Chinese Medicine (TCM), and Southeast Asian herbal traditions.
Research Narrative (Provisional)
A 2023 study in Chemical Biodiversity (PMID 36892132) demonstrated that both acetylated and non-acetylated clove bud essential oils exhibit potent antibacterial activity, with eugenol and eugenyl acetate as key bioactive compounds against multiple bacterial strains. Ibrahim et al. (2023) in the Journal of Physiology and Pharmacology (PMID 38085521) showed that clove bud extract and its phytogenic silver nanoparticles possess significant immunomodulatory and anti-cancer properties, modulating immune cell activity and inducing apoptosis in cancer cell lines. Nirmala et al. (2019) in the International Journal of Nanomedicine (PMID 31496696) developed a clove bud essential oil-based nanoscale emulsion demonstrating both anticancer activity against human colorectal adenocarcinoma cells and antibacterial effects against E. coli and S. aureus. Additionally, El-Moslemany et al. (2023) in Toxics (PMID 37755735) provided mechanistic evidence that clove buds protect against metronidazole-induced neurotoxicity in rats through antioxidant restoration, neurotransmitter modulation, and cytokine regulation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Eugenol, Polyphenols, Flavonoids, Tannins: Potent antimicrobial, anti-inflammatory, and antioxidant compounds. - Volatile oils, Phenolic compounds: Contribute to immune-boosting and anti-inflammatory effects. - Beta-caryophyllene: Provides anti-inflammatory and analgesic properties. - Vitamin C, Vitamin K, B-complex vitamins: Support immune resilience, blood clotting, and nervous system function. - Manganese, Calcium, Magnesium, Potassium, Phosphorus, Iron: Essential minerals for bone health, electrolyte balance, and metabolic processes. - Dietary fiber: Supports digestive health.
Reported Mechanism (Provisional)
Eugenol, the principal phenylpropanoid in clove bud oil, partitions into bacterial phospholipid bilayers, causing rapid membrane depolarization, potassium and ATP efflux, and collapse of the proton-motive force — ultimately leading to cell lysis; it also inhibits key TCA cycle enzymes including citrate synthase and α-ketoglutarate dehydrogenase, halting bacterial energy metabolism. Its analgesic action is mediated through inhibition of cyclooxygenase-2 (COX-2) and suppression of prostaglandin E2 (PGE₂) synthesis, while also blocking voltage-gated sodium channels in nociceptive neurons to attenuate pain signaling. Eugenol's antioxidant mechanism involves direct scavenging of hydroxyl, superoxide, and DPPH radicals via its phenolic hydroxyl group, with concurrent upregulation of endogenous enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), as supported by its neuroprotective effects demonstrated via antioxidant restoration and cytokine modulation (PMID 37755735). Immunomodulatory activity is exerted through suppression of NF-κB nuclear translocation and downstream pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), contributing to the anti-cancer and anti-inflammatory profiles observed in phytogenic nanoparticle formulations (PMID 38085521).
Clinical Narrative (Provisional)
Current evidence relies primarily on in vitro studies demonstrating antimicrobial activity against E. coli, S. aureus, P. aeruginosa, and Candida species. Laboratory data shows EC₅₀ values of 32-50 µg/mL for reducing power and 98.6% DPPH radical scavenging at 800 µg/mL. No human randomized controlled trials with quantified clinical endpoints are available in current literature. Evidence strength remains limited to preclinical mechanistic studies without validated therapeutic dosing or efficacy data in human subjects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.